Objective: To describe the prevalence, characteristics and outcomes of amphetamine-related presentations to a tertiary hospital emergency department (ED).
Design, Setting And Participants: Prospective observational study of amphetamine-related presentations to the ED of the Royal Perth Hospital (RPH), an adult, inner-city, tertiary referral hospital, between 3 August and 2 November 2005. For all patients presenting to the ED, the treating doctors were automatically prompted by the computerised data entry system to consider amphetamine use.
Main Outcome Measures: Proportion of ED presentations related to amphetamine use; demographic features and usage practices of amphetamine users; characteristics of presentations and admissions; associated psychiatric illnesses and use of other drugs.
Results: Over the study period, there were 13 125 presentations, of which 156 (1.2%) were judged to be causally related to amphetamine use. Of those 156 patients, over half were habitual drug users (89 [57.1%] used amphetamines at least weekly), and the majority were men (111 [71.2%]). The mean age was 28 years (range, 16-55 years). Presentations were of high acuity: 104 patients [66.7%] were rated 1, 2 or 3 on the Australasian Triage Scale; 50 (32.1%) arrived by ambulance; and 25 (16.0%) arrived with police. The mean time spent in the ED was 6 h (range, 0.5-24 h). Fifty patients (32.1%) required sedation, and the likelihood of requiring sedation increased almost threefold if the heart rate was over 100 beats/min on presentation. Sixty-two patients (39.7%) were admitted and 58 (37.2%) required psychiatric evaluation. Repeat attendance was common, with 71 patients (45.5%) having previous amphetamine-related presentations to the RPH ED.
Conclusions: Amphetamine-related presentations comprise 1.2% of all ED attendances and have a major impact on hospital EDs. Patients are often agitated and aggressive, require extensive resources, and frequently re-attend. The burden of amphetamine-related illnesses on EDs is likely to increase in the future.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5694/j.1326-5377.2007.tb00932.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Left ventricular dissecting haematoma and aneurysm formation in a patient who uses methamphetamines: a case report.
BMC Cardiovasc Disord
December 2024
Institute of Cardiology, National Hospital of Sri Lanka, Colombo, Sri Lanka.
Article Synopsis
- Myocardial dissection is a rare but serious complication of ischaemic heart disease, characterized by a haematoma forming within the cardiac muscle, often triggered by factors such as increased wall tension and reduced tensile strength.
- A case study highlights a 37-year-old male, who developed myocardial dissection following an ST elevation infarction after years of substance abuse, including heroin and methamphetamines, which might be linked to his condition.
- The patient presented with symptoms of heart failure, and diagnostic tests revealed severe heart dysfunction and a mass in the heart, leading to treatment with diuretics and medical therapy instead of surgery due to high operative risk.
Integration of pharmacochemistry, pharmacodynamics and metabolomics to reveal active ingredients and mechanism of Nan Bao detox capsule alleviating methamphetamine addiction.
Addict Biol
November 2024
Hunan Academy of Chinese Medicine, Changsha, China.
Article Synopsis
- Nan Bao detox capsule (NBDC) is based on ancient Chinese methods and shows potential in treating substance abuse, especially for methamphetamine addiction.
- The study identified key active ingredients in NBDC and tested its effects in a rat model, showing improvements in behavior and neurotransmitter levels, such as increased dopamine and serotonin.
- Metabolomic analysis highlighted the histamine receptor as a target and linked NBDC to metabolic pathways relevant to cocaine addiction and Parkinson's disease, suggesting its multi-faceted therapeutic action against methamphetamine addiction.
Co-abuse of amphetamine and alcohol harms kidney and liver.
Sci Rep
October 2024
Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Al Qassim, 51452, Buraydah, Saudi Arabia.
Article Synopsis
- The study found that people who abused both alcohol and amphetamines had a much higher risk of health problems compared to those who only used one or neither!
- Researchers tested 100 participants (75 with substance abuse issues and 25 healthy individuals) to see how these drugs affected the liver and kidneys!
- Results showed that all drug abusers had liver problems and changes in blood tests, but those who only drank alcohol had different blood sugar levels compared to others!
California's Recovery Incentives Program: Implementation strategies.
J Subst Use Addict Treat
December 2024
Vermont Center on Behavior and Health, Center on Rural Addictions, Burlington, VT, United States of America; Department of Psychiatry, University of Vermont, Burlington, VT, United States of America.
Article Synopsis
- The increasing issue of stimulant use disorder (StimUD) in the US, particularly related to psychostimulants, has prompted California to implement a large-scale treatment initiative called the Recovery Incentives Program, utilizing contingency management (CM).
- The program employs the Science to Service Lab (SSL) approach, which includes training, feedback, and facilitation, enhanced with additional readiness assessments and ongoing monitoring of implementation fidelity.
- Initial findings suggest that the program is well-received by both treatment staff and participants, with plans for further evaluations to assess member progress and the ongoing effectiveness of the training and implementation strategies.
Opposite Contractile Effects of Amphetamine-Related Hallucinogenic Drugs in the Isolated Human Atrium.
Int J Mol Sci
August 2024
Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06097 Halle, Germany.
The present study examined three hallucinogenic amphetamine derivatives, namely, 2,5-dimethoxy-4-iodoamphetamine (DOI) as well as 2,5-dimethoxy-4-methylamphetamine (DOM) and 4-methylmethcathinone (mephedrone). The objective of this study was to test the hypothesis that DOI, DOM, and mephedrone would increase the contractile force in isolated human atrial preparations in a manner similar to amphetamine. To this end, we measured contractile force under isometric conditions in electrically stimulated (1 Hz) human atrial preparations obtained during open surgery.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!